Drug Shortage Report for AA-FENO-SUPER

Last updated on 2018-05-15 History
Report ID 3524
Drug Identification Number 02246860
Brand name APO-FENO-SUPER
Common or Proper name FENOFIBRATE
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) FENOFIBRATE
Strength(s) 160MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BLS
ATC code C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-18
Estimated end date 2018-06-22
Actual end date 2018-05-11
Shortage status Resolved
Updated date 2018-05-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v44 2018-05-15 French Compare
v43 2018-05-15 English Compare
v42 2018-04-16 French Compare
v41 2018-04-16 English Compare
v40 2018-04-15 French Compare
v39 2018-04-15 English Compare
v38 2018-03-20 French Compare
v37 2018-03-20 English Compare
v36 2018-03-13 French Compare
v35 2018-03-13 English Compare
v34 2018-02-21 French Compare
v33 2018-02-21 English Compare
v32 2018-02-12 French Compare
v31 2018-02-12 English Compare
v30 2018-01-31 French Compare
v29 2018-01-31 English Compare
v28 2017-12-04 French Compare
v27 2017-12-04 English Compare
v26 2017-11-13 French Compare
v25 2017-11-13 English Compare

Showing 1 to 20 of 44